Differentiated T helper 1 (Th1) and T helper 2 (Th2) T-cells show striking differences in their patterns of cytokine expression. This process is initiated by stimulation with antigen and the cytokines IL-12 and IL-4, respectively, and requires antigen-induced transcription factors such as NFAT and cytokine-induced transcription factors such as STAT4, induced by IL-12, and STAT6, induced by IL-4. This results in induction and maintained expression of subset-specific transcription factors including T-bet in Th1 cells and GATA3 in Th2 cells, which are involved in ensuring the commitment of T-cells to Th1 or Th2 lineages. Here we review the signalling pathways and transcription factors that mediate T-cell differentiation, and describe the epigenetic changes in chromatin structure, locus accessibility and DNA methylation that are known to accompany this process.
T-cells undergoing an immune response show varying patterns of cytokine production. The most discernible patterns are represented in both T helper and T cytolytic populations, and have been termed type 1 and type 2 (reviewed by Mossman & Coffman 1 ). The patterns were originally identified by analysis of murine CD4 + T helper cell clones. T helper 1 (Thl) cells were defined as producing IFN-y, TNF and lymphotoxin, but not IL-4, IL-5 or IL-13; while Th2 cells were defined as producing IL-4, IL-5, H-9, IL-10 and IL-13 but not IFN-y. While many established T-cell clones completely fit the Thl/Th2 paradigm in terms of non-overlapping patterns of IL-4 and IFN-y expression, under physiological conditions the paradigm is more applicable to populations than to single cells (reviewed by Kelso 2 ). The strongest in vivo levels of Thl/Th2 polarisation are elicited by chronic antigen stimulation; in particular, highly polarised Thl and Th2 patterns of cytokine production are associated with states of chronic microbial and parasitic infections, respectively (reviewed by Abbas et aP) . With less chronic exposure to antigen, Thl and Th2 patterns of cytokine expression may still be apparent at the population level, but individual T-cells show varied and complex patterns of cytokine expression (reviewed by Fitzpatrick & Kelso 4 ).
There are several features other than cytokine production that, at least at a population level, distinguish Thl and Th2 cell populations (reviewed elsewhere 5 " 7 ) . Among these are several cytokine, chemokine and adhesion receptors, which presumably influence the migration and homing of differentiated T-cells and their responses to their immediate environment. Thus the IL-12 receptor p chain, the IFN-y receptor (3 chain on Thl cells, and the chemokine receptors CXCR3 and CCR5 are preferentially expressed on Thl cells, while CCR3 (the eotaxin receptor), a novel EL-1-like molecule, T1/ST2, and the chemokine receptors CCR4 and CCR8 are preferentially expressed on Th2 cells. Thl and Th2 cells are also distinguished by their differential expression of certain transcription factors (ERM and T-bet in Thl cells, GATA-3 and cMaf in Th2 cells) that are important in maintaining the differential patterns of cytokine expression. The functional importance of some of these molecules will become apparent in the discussions below. This review deals with the molecular basis for production of the signature cytokines of Thl and Th2 cells, IFN-y and IL-4/IL-5/IL-13. The latter three genes are grouped together since they are closely linked and reside within a ~200 kb genomic interval on a single chromosome in all mammalian species tested 8 ' 9 . The IL-4, IL-5 and IL-13 genes are also coexpressed in mast cells, suggesting that their expression is coordinately regulated over a large chromosomal interval (although there is also evidence for non-coordinate regulation). The signalling pathways, the transcription factors, and the chromatin-based processes involved in IFNy and IL-4/IL-5/EL-13 gene transcription are briefly described.
The Th1/Th2 classification in disease
The Thl/Th2 classification has been most useful when relating overall patterns of cytokine production to clinical outcomes in a variety of pathological states (reviewed by Abbas et aP). Thl patterns of cytokine production have protective functions in microbial infections. This is particularly apparent in leprosy, where the healing (tuberculoid) form of leprosy is associated with a predominant Thl cytokine pattern and strong delayed-type hypersensitivity (DTH) responses, while uncontrolled lepromatous lesions are characterised by a Th2 cytokine pattern and weak DTH but high antibody titres. The clinical outcomes of microbial infections can be predicted based on the biological functions of the cytokines produced (reviewed by Abbas et aP). The principal Thl effector cytokine, IFN-y, activates effector macrophages, promoting their ability to ingest and destroy microbes. Together with IL-2, EFN-y promotes the differentiation of CD 8 T-cells into actively cytotoxic cells. Together with TNF-(3, it recruits and activates inflammatory leukocytes. Thus Thldominated immune responses are associated with the presence of activated macrophages and cytolytic T-cells. In industrialised countries where there is less exposure to microbial infections, Thl-type cytokine patterns are observed clinically in cases of chronic inflammation, tissue injury, and autoimmune disease.
In contrast, Th2-type cytokine patterns are strongly apparent in parasitic infections, although whether they are truly protective is controversial (reviewed by Abbas et aP). Th2 cytokine responses are clearly associated with deleterious allergic reactions to environmental antigens and with the development of chronic bronchial inflammation and airways hyperresponsiveness in asthma (reviewed elsewhere 10 ' 11 ). The Th2 cytokine IL-4 is the principal agent that induces B cell switching to IgE production. IgE binds almost irreversibly to the IgE receptor on mast cells, and its crosslinking by multivalent antigens leads to the release of diverse inflammatory mediators 11 . The biological functions of IL-13 partially overlap with those of IL-4, possibly because the receptors for these two cytokines share a common subunit, the a-chain of the IL-4 receptor 12 . In mice, IL-13 induces many features of asthma, such as airway hyperresponsiveness and hypersecretion of mucus, without inducing eosinophilic inflammation 13 . The later stages of allergic asthma, which are characterised by eosinophilia and chronic tissue inflammation, appear to be mediated by IL-5, the principal cytokine responsible for eosinophil activation 14 . IL-5 is highly effective at releasing eosinophils and their precursors from the bone marrow. A single injection of anti-IL-5 diminishes the number of circulating eosinophils in an effect that lasts for several weeks, and 'knockout' mice lacking IL-5 or its receptor show marked defects in eosinophil responses to helminths (reviewed elsewhere 
Signalling pathways and transcription factors underlying T-cell differentiation
The signalling pathways that contribute to Th differentiation are relatively well understood, with the best-characterised being those initiated by cytokines (reviewed elsewhere 5 " 7 ). IL-12, IFN-a and IL-18 play a major role in promoting Thl differentiation, while EL-4 (and to some extent IL-13) are the key cytokines that determine Th2 differentiation (Fig. 1) . However, the nature of the antigen-presenting cell, the strength of stimulation with antigen, and the level and nature of co-stimulation also play important roles. This review will focus only on the most well-established pathways; for a discussion of other factors, the reader is referred to several excellent and recent reviews the mouse, EL-12 induces Thl differentiation while IFN-a has no effect; in contrast, Thl differentiation of human T-cells can be induced by either EL-12 or EFN-ot, although EFN-a may play the predominant role in controlling EFN-y production in vivo. In humans, both IL-12 and EFN-a act through the STAT transcription factor STAT4, while only EL-12 induces STAT4 in the mouse. Mice deficient in EL-12 or STAT4 show a strong defect in EFNy production by CD4 T-cells, although EFN-y production by CD8 T-cells is much less affeaed. Moreover, mice deficient in both STAT4 and STAT6 are capable of mounting Thl responses, apparently because of the existence of an alternate STAT4-independent pathway of IFN-y production that is suppressed by STAT6 17 . Indeed, STAT1, which is also induced by both IFN-a and IL-12, may substitute for STAT4 in human T-cells and in murine CD8 T-cells.
The cytokine IL-18 is related to IL-1 and, like IL-1, is coupled to activation of the transcription factor NFKB (reviewed by Akira 18 ). IL-18 synergises powerfully with IL-12 to promote Thl differentiation, in part by increasing the efficiency of Thl differentiation and in part by acting on differentiated Thl cells to enhance cytokine expression. Mice deficient in both IL-12 and EL-18 have a much more severe defect in IFN-y production than mice lacking IL-12 or IL-18 alone.
The control of Thl differentiation by IL-12 and IFN-a forms the basis for a powerful positive feedback loop that enhances IFN-y production during microbial and viral infections (reviewed elsewhere 3 " 7 and Fig. 1 ). In the first arm of the positive feedback loop, microbial products such as endotoxin activate macrophages and induce IL-2 production. Likewise viral infections increase the production of type I interferons such as IFN-a by the infected cells. These cytokines, IL-12 and IFN-a, then act on naive T-cells to induce Thl differentiation and IFN-y production. The positive feedback loop is completed when IFN-y produced by the differentiated Thl cells further activates macrophages and potentiates their ability to produce IL-12. Thus the initial response of macrophages to microbial infections (IL-12 production) is exactly that needed to promote the development of the T-cell subset which, by producing IFN-y, further activates them and enhances their microbicidal activity.
Two transcription factors, T-bet and ERM, have been described that are induced by STAT4 and T-cell receptor stimulation (reviewed elsewhere . As expected, both T-bet and ERM are preferentially expressed in Thl cells relative to Th2 cells. However, ERM does not promote IFN-y production when introduced into differentiating Th2 cells. In contrast, ectopic expression of T-bet in a variety of cell types leads to strong expression of IFN-y and several Thl-specific cell surface receptors. Moreover, T-bet overexpression leads to down-regulation of the expression of IL-2 and several Th2-specific cytokines, suggesting that this transcription factor play a central role in promoting not only the development and maintenance of the Thl phenotype but also suppression of the Th2 phenotype. The mechanistic basis for T-bet function is not yet well-understood; in particular, it is unclear whether expression of the IFN-y gene and other Thl-specific genes requires direct binding of T-bet to one or more regulatory regions of these genes, or whether T-bet induces secondary transcription factors that contribute to gene expression.
Th2 differentiation
The cytokine IL-4, acting through the IL-4-induced transcription factor STAT6, exerts the single most powerful positive influence on T-cell differentiation towards the Th2 phenotype (reviewed elsewhere 3 " 7 - 15 and Fig.l) . T-cells from STAT6-deficient mice are strongly suppressed for Th2 differentiation, although a small number of IL-4 producing cells can occasionally be observed 21 . T-cells from IL-4-deficient mice show a less striking phenotype on average; this is attributed to the fact that IL-13 also induces STAT6, since mice doubly deficient for IL-4 and IL-13 are as defective as STAT6~/ mice in their ability to produce Th2 cells. Ectopic expression of activated STAT6 in differentiating T-cells induces IL-4 production as shown by the use of a conditional STAT6-oestrogen receptor fusion protein that can be activated by tamoxifen without the need for IL-4 22 . These conditions also result in up-regulation of two transcription factors, GATA3 and cMaf (Maf), that are known to be preferentially expressed in Th2 cells relative to Thl cells An alternate STAT6-independent pathway for Th2 differentiation has become apparent through studies of the transcriptional repressor BCL-6. Mice lacking BCL-6 display a profound Th2 bias 30 , possibly because BCL-6 competes with STAT6 for binding sites in DNA and then is capable of recruiting transcriptional co-repressor complexes containing histone deacetylases to the relevant genes 30 ' 31 . Interestingly, the Th2 bias observed in BCL-6-deficient T-cells is not dependent on STAT6, since a very similar degree of Th2 bias is observed in T-cells singly deficient for BCL-6 or doubly deficient for both BCL-6 and STAT6
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; in contrast, T-cells lacking only STAT6 are only poorly capable of Th2 differentiation 3 " 7 . The possibilities are that BCL-6 inhibits a STAT6-independent pathway of Th2 differentiation, or that in the absence of the repressive influence exerted by BCL-6, the positive influence of STAT6 becomes less crucial for achieving the differentiated Th2 phenotype.
Negative feedback effects, mixed inputs and mixed phenotypes
In addition to the positive feedback pathways, there are strong negative feedback mechanisms by which EL-4, STAT6, GATA3 and Maf act to maintain the Th2 phenotype of differentiated T-cells and to downregulate Thl cytokine expression (Fig. 2) . IL-4 has long been known to down-regulate IFN-y production, and this effect appears to be mediated through the STAT6 target gene products GATA3 and Maf. Ectopic expression of GATA-3 or Maf, even in IL-4-deficient naive T-cells, results in marked inhibition of IFN-y production by Thl cells 21 ' 26 ' 28 . In contrast, forced expression of GATA-3 in established Thl clones had little effect, indicating that the down-regulatory effects of GATA3 were not due to direct repression of IFN-y gene transcription in stimulated Thl cells, but rather were exerted at an earlier step of differentiation 21 " 26 . ). Ectopic expression of GATA3 in murine Thl cells also resulted in down-regulation of IL-12RP2 chain expression, indicating that this down-regulation is also mediated by GATA3 33 .
It is important to note, however, that cytokine production under conditions of mixed Thl/Th2 stimulation conditions reflects a balance between the different inputs prevailing in the culture environment (reviewed elsewhere 
Regulation of cytokine gene expression at the level of chromatin accessibility

General considerations
The inference from all these studies is that the conditions prevailing during the first antigen stimulation of a naive T-cell play a major role in determining the pattern of cytokine production by the differentiated progeny of that T-cell. Furthermore, many studies have established that naive T-cells make very low levels of cytokines relative to a fullydifferentiated Thl or Th2 cell 34 ' 35 . For instance, a naive T-cell produces in a 24-48 h period an amount of cytokine protein that is typically at least 1000-fold lower than that produced by a fully-differentiated T-cell within 2-4 h after stimulation 34 " 35 . Several days of antigen/cytokine exposure are typically needed to achieve the fully-differentiated state, and this has been traced to a requirement for cell division 36 " 37 . While the cytokine IL-2 is produced by antigen-stimulated naive T-cells even prior to S phase, production of other cytokines becomes detectable by intracellular cytokine staining only after a characteristic number of cell divisions. For instance, DFN-y production becomes apparent after one cycle of cell division, while IL-4 production is observed after 3-4 cycles . As summarised below, the first exposure of the naive T-cell to antigen and cytokine results in specific changes in chromatin structure and DNA methylation of the relevant cytokine genes. These changes are termed epigenetic because they are determined not by the intrinsic nucleotide sequence information encoded in the DNA, but rather by modification of nucleosomal histones and of cytosine residues in DNA. So far the best-studied epigenetic modifications are histone acetylation and DNA methylation (reviewed elsewhere 44 ' 45 ) ; genes that are active ('open') in a particular tissue or cell type show increased histone acetylation and decreased methylation of cytosine-guanine (CpG) pairs, while genes that are inactive ('closed') are characterised by highly condensed chromatin, decreased histone acetylation, and dense CpG methylation. These modifications determine the level of cell type-specific gene transcription by modulating the accessibility of the relevant genes to the correct transcription factors, coactivator proteins, basal transcription apparatus, and RNA polymerase II. Epigenetic patterning is heritable, ensuring that once 'open', the cytokine loci remain accessible even in cells that have been rested for long periods in the absence of stimulation. This feature of effective irreversibility is characteristic of differentiative processes in general, and in the immune system may underlie T-cell memory.
Why are several cycles of cell division necessary for optimal differentiation? Data from other systems suggest that the process of locus 'opening' involves many sequential steps which may take several days to complete. The initial changes in chromatin structure often involve repositioning of nucleosomes away from transcription factor-binding regulatory regions of the gene, as well as long-range changes in the modification status of histones and in the methylation state of cytosine residues in DNA. These processes are likely to be initiated through the coordinate actions of antigen-and cytokine-induced transcription factors such as NFAT and STAT proteins, respectively, but be maintained by subsetspecific transcription factors such as GATA3, Maf and T-bet (reviewed by Agarwal et al 42 ) . Together, the early and late-acting factors are thought to recruit chromatin remodeling complexes and histone-modifying enzymes to key regulatory regions of the cytokine genes. The subset-specific factors and the secondary proteins may not be present at sufficient levels or be able to gain sufficient access to DNA unless the cells have gone through one or more cycles of DNA replication when chromatin disassembly occurs, thus explaining the cell cycle requirement for optimal cytokine production.
Summary of experimental evidence
DNase I hypersensitivity A useful technique for gauging gene 'accessibility' in the chromatin context is to monitor the sensitivity of the relevant DNA sequences to digestion with DNase I in intact nuclei (reviewed by Ng & Bird 4 *). Many kilobases of DNA within and around the gene of interest can be monitored by this method. In general, genes located in active chromatin, that are actively transcribed or have the potential to be transcribed upon appropriate stimulation, are more sensitive to DNase I digestion than genes present in inactive or 'closed' chromatin, which are not expressed in the cell type or developmental stage under investigation. The technique is generally used, however, to identify regions of strong DNase I 'hyper' sensitivity, which often reflect perturbations introduced by protein binding to nucleosomal DNA and thus correlate with critical regulatory regions of the gene (e.g. inducible or tissue-specific enhancers, locus control regions, matrix attachment regions, insulators/boundary elements, or sites of relief from transcriptional attenuation (reviewed by Gross & Garrard 47 ). Careful mapping of DNase I hypersensitive sites can reveal binding sites for key transcription factors within or immediately adjacent to the hypersensitive regions themselves 29 . Two recent studies showed that Thl and Th2 differentiation are accompanied by long-range changes in DNase I hypersensitivity of the cytokine genes that are destined to be transcribed by the differentiated Tcells upon secondary stimulation (reviewed elsewhere 41 >42 ) 38)39 . Naive Tcells have very simple patterns of DNase I hypersensitivity on the IFN-y, IL-4 and IL-13 genes. During Thl differentiation, a complex pattern of DNase I hypersensitivity, with appearance of three DNase I hypersensitive sites, develops specifically on the IFN-y gene but not on the EL-4 and IL-13 genes 38 ; conversely, Th2 differentiation is accompanied by development of at least 10 Th2-specific clusters of DNase I hypersensitive sites in the IL-4 and IL-13 genes but no change in the IFN-y gene 38 * 39 . These changes in DNase I hypersensitivity are apparent within 48 h of initial stimulation of the naive T-cells, and require stimulation with both antigen and the appropriate cytokine 38 . The above experiments were performed on resting cells that were not actively transcribing the cytokine genes. Agarwal et aV 3 showed that, upon stimulation, one of the DNase I hypersensitive sites in the EFN-y gene was attenuated in its intensity, while a new, strongly inducible site developed in the 3' region of the IL-4 gene. This region bound the Th2-specific transcription factor GATA3 in vivo and behaved as an inducible, Th2-specific enhancer in transient reporter assays. Moreover, this 3' IL-4 enhancer bound selectively to the antigen-inducible transcription factor NFAT in Th2 cells but not Thl cells, despite the equivalent activation of NFAT in both Thl and Th2 cell types. This result indicated that the selective expression of the IL-4 gene in Th2 cells was, in part, due to its selective accessibility at the chromatin level. Two constitutive and Th2-specific DNase I hypersensitive sites, HSS1 and HSS2, are present in the intergenic region between the IL-4 and IL-13 genes 39 . These sites are contained within a region, CNS-1 (conserved non-coding sequence-1) whose sequence is strongly conserved in all mammalian species 9 . Transgenic mice carrying yeast artificial chromosomes containing the human IL-4/IL-5/IL-13 locus showed appropriate expression of the human cytokines in Thl, Th2 and NK Tcells; when CNS-1 was deleted from the transgene by Cre-mediated recombination, there was a 50-70% decrease in the number of Th2 cells expressing human IL-4 and IL-13, without a significant effect on the level of cytokine expression per cell. CNS-1 also affected expression of the human IL-5 gene, located 120 kb away; but did not affect expression of the nearby RAD50 and KIF3 genes (ubiquitous and brain-specific, respectively). Thus CNS-1 appears to act selectively over long distances to increase the probability of IL-4/IL-5/IL-13 gene expression in the context of chromatin. This behaviour is reminiscent of locus control regions and certain enhancers, which can induce uniform expression and suppress silencing of transgenes that have been integrated into repressive locations such as centromeres (reviewed elsewhere 48 ' 49 ).
DNA demethylation
In general, silent genes are embedded in regions of hypermethylated DNA, while active genes are marked by hypomethylation. This is because methylated DNA recruits the methyl-CpG-binding protein MeCP2, that in turn recruits co-repressors such as the SIN3 histone deacetylase complex (reviewed by Strahl & Allis 45 ). Most DNA methylation occurs symmetrically on CpG dinucleotides. During DNA replication, unmethylated cytosine becomes incorporated into the newly synthesised DNA strand, and thus the daughter strands contain hemimethylated CpGs. This structure is recognised and rapidly remethylated by DNA methyltransferases, which, therefore, recreate fully-methylated CpG dinucleotides and stably maintain DNA methylation status through multiple cycles of cell division (reviewed elsewhere Bird et aP 6 reported that IL-4 production by differentiating Th2 cells was accompanied by CpG demethylation of the IL-4 and IL-5 genes. Likewise, several groups have shown that hypomethylation of the IFNy gene correlates with increased IFN-y gene expression in Thl cells (reviewed elsewhere 41 ' 42 ) . The mechanisms, which promote demethylation of cell type-specific genes, have not yet been elucidated. One possibility is that the nucleosome displacement that occurs during DNA replication allows cell-specific transcription factors to bind to DNA, and that the stable transcription complex established thereby interferes locally with maintenance methylation. This process would result in slow, cell-cycle-dependent demethylation. Alternatively, demethylation could occur in a cell-cycle-independent manner via an active demethylase.
An overall model for cytokine gene expression
We have proposed that cytokine gene expression may be envisioned as occurring in three distinct stages (reviewed elsewhere 41 ' 42 see Fig.3 ).
Initiation phase
The initiation phase is highly dependent on antigen, antigen-induced transcription factors such as NFAT and NFKB, cytokines, and cytokineinduced STAT factors. Although these factors may initiate the process of locus remodelling, their activation is transient and is rapidly terminated in the absence of continued stimulation. As such, other factors and processes must be involved in maintaining the accessibility of cytokine loci in differentiated resting T-cells. We postulate that the transiently-activated transcription factors use a 'hit-and-run' mechanism to initiate locus remodelling and cytokine gene expression, by activating a differentiationspecific genetic programme following the initial stimulation with antigen and cytokines. This results in the stable expression of cell type-specific nuclear factors in the differentiated cells, including (but not necessarily limited to) GATA3 and Maf in Th2 cells and ERM and T-bet in Thl cells.
Commitment phase
The commitment phase of T-cell differentiation is mediated by cell typespecific nuclear factors such as those listed above. During this phase, the differentiated phenotype is stabilised and maintained in the absence of further stimulation. A likely mechanism invokes the binding of these cell type-specific factors to dispersed regulatory elements in the cytokine genes, thereby recruiting histone acetyltransferases and chromatin remodelling enzymes to the appropriate genetic loci. The resulting chromatin configurations are stably inherited as described above, and persist in differentiated cells in the absence of active transcription.
Final phase
The final phase of acute gene transcription is elicited by secondary contact of the differentiated T-ceils with antigen. This process involves binding of antigen-induced transcription factors such as NFAT to promoters and distal enhancer regions of cytokine genes. We have demonstrated 29 that, despite the fact that antigen-induced transcription factors are equivalently induced in both Thl and Th2 cells, their access to these regulatory regions is limited by the prior process of cell typespecific chromatin remodelling that has occurred on the cytokine genes during the earlier differentiative phase. It has been shown in other systems that even the acute phase of gene transcription involves recruitment of ATP-dependent chromatin remodelling enzymes and histone acetyltransferases to promoter/enhancer regions of genes 50 .
Conclusions
It should be apparent from this discussion that gene transcription is a truly dynamic process. The first steps of gene expression occur concomitantly with cell differentiation, and involve extensive changes in chromatin structure, sometimes occurring over hundreds of kilobases of DNA. These changes typically involve increased sensitivity to digestion by nucleases and restriction enzymes, increased histone acetylation of nucleosomal DNA, and decreased density of DNA methylation on CpG dinucleotides. The changes signal the acquisition of transcriptional competence, which precedes the overt transcription of lineage-specific genes. In the case of peripheral T-cells, the differentiation programme is initiated in response to first antigen contact, while overt gene transcription is delayed until later encounters with antigen. Full commitment to a specific lineage is established gradually and eventually becomes irreversible.
